October 19-22 2018, Munich, Germany. Dr Razis, Dr Labropoulos and Dr Rigakos attended the 2018 European Society for Medical Oncology (ESMO) Congress. Dr Razis participated as a co-presenter of two Hellenic Cooperative Oncology Group (HeCOG) posters on the “Cyclin D1 differential activation and its prognostic impact among advanced breast cancer patients treated with trastuzumab” and “Actionable Mutations and Overall Survival in 3,211 Patients with Cancer: The Hellenic Cooperative Oncology Group Precision Medicine Initiative”. In addition, she participated in the Breast International Group (BIG) Scientific Meeting, as representative of the Hellenic Cooperative Oncology Group (HeCOG) in the Breast International Group.
Leave a Reply